Blade Therapeutics starts Phase l trial of BLD-2660 for fibrosis
Blade Therapeutics has commenced a Phase l clinical trial to investigate the safety and pharmacokinetics (PK) of BLD-2660 for the…
fibrosis Blade Therapeutics
Blade Therapeutics has commenced a Phase l clinical trial to investigate the safety and pharmacokinetics (PK) of BLD-2660 for the…